Vascular endothelial growth factor (VEGF) expression in oral tissues: Possible relevance to angiogenesis, tumour progression and field cancerisation

Journal of Oral Pathology and Medicine

Volumn 30, Issue 8, 2001, Pages 449-457

  Carlile, J ^a   Harada, K ^a,b   Baillie, R ^a   Macluskey, M ^a   Chisholm, D M ^a   Ogden, G R ^a   Schor, S L ^a   Schor, A M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Angiogenesis; Disease progression; Dysplasia; Field cancerisation; Normal mucosa; Oral tissues; Tumour; Vascular endothelial growth factor (VEGF)

Indexed keywords

EID: 0034870806     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2001.030008449.x     Document Type: Article

References (35)

1. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
2. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation
3. Molecular and biological properties of vascular endothelial growth factor
4. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors
5. Expression of vascular endothelial growth factor in normal epidermis, epithelial tumours and cultured keratinocytes
6. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis
7. Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer
8. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer
9. Vascular endothelial growth factor in squamous cell head and neck carcinoma: Expression and prognostic significance
10. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression
11. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma
12. Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: Its association with tumour progression and p53 gene status
13. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals
14. Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: An immunohistochemical study
15. Vascular endothelial growth factor is a marker of tumour invasion and metastasis in squamous cell carcinoma of the head and neck
16. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma
17. Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck
18. Prognostic significance of vascular endothelial growth factor protein levels in oral and orolpharyngeal squamous cell carcinoma
19. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis
20. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinoma
21. Field cancerisation in the head and neck
22. Field change, clonality, and early epithelial cancer: Possible lessons from p53
23. The natural history and pathology of oral cancer and precancer
24. The association between tumour progression and vascularity in the oral mucosa
25. Apoptosis, proliferation and angiogenesis in oral tissues. Possible relevance to tumour progression
26. Definitions of terms related to oral cancer and precancer
27. Assessment of vascularity in histological sections: Effects of methodology and value as an index of angiogenesis in breast tumours
28. Angiogenesis in the neoplatic sequence of Barrett's oesophagus. Correlation with VEGF expression
29. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma
30. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
31. Angiogenic cytokines in mesothelioma: A study of VEGF, FGF-1 and -2, and TGF beta expression
32. Vascular endothelial growth factor in normal human salivary glands and saliva: A possible role in the maintenance of mucosal homeostasis
33. Relationships between different measurements of vascularity and clinico-pathological parameters in breast cancer
34. Tumour angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: A clinical-pathological correlation
35. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia